Imaging and Pathology of Ductal Carcinoma in Situ of the Breast: The Forest and the Trees.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Integration of eQTL and GEO Datasets to Identify Genes Associated with Breast Ductal Carcinoma In Situ.Current issues in molecular biology · 2025
   Article
2. Super-Resolution Ultrasound Radiomics Can Predict the Upstaging of Ductal Carcinoma In Situ.Cancer medicine · 2025
   Article
3. Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma in Situ to Invasive Carcinoma.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
   Article
4. Ultrasound characteristics comparison and development of a predictive nomogram for intraductal papilloma and ductal carcinomaFrontiers in oncology · 2025
   Article

Corrections and comments

• Comment on
  US, Mammography, and Histopathologic Evaluation to Identify Low Nuclear Grade Ductal Carcinoma in Situ.2022

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as